发明申请
US20120253039A1 Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds
审中-公开
用2,4-嘧啶二胺化合物治疗或预防自身免疫性疾病的方法
- 专利标题： Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds
- 专利标题（中）： 用2,4-嘧啶二胺化合物治疗或预防自身免疫性疾病的方法
-
申请号： US13442480申请日： 2012-04-09
-
公开(公告)号： US20120253039A1公开(公告)日： 2012-10-04
- 发明人: Rajinder Singh , Ankush Argade , Hui Li , Somasekhar Bhamidipati , David Carroll , Catherine Sylvain , Jeffrey Clough , Holger Keim
- 申请人： Rajinder Singh , Ankush Argade , Hui Li , Somasekhar Bhamidipati , David Carroll , Catherine Sylvain , Jeffrey Clough , Holger Keim
- 申请人地址： US CA South San Francisco
- 专利权人： RIGEL PHARMACEUTICALS, INC.
- 当前专利权人： RIGEL PHARMACEUTICALS, INC.
- 当前专利权人地址： US CA South San Francisco
- 主分类号： C07D498/04
- IPC分类号： C07D498/04 ; C07D403/12 ; C07D495/04 ; C07D491/056 ; C07D413/12 ; C07D497/04 ; C07D513/04 ; C07D471/04
摘要：
The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lupus erythematosis and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.
信息查询
